1. Home
  2. ASMB vs MGYR Comparison

ASMB vs MGYR Comparison

Compare ASMB & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • MGYR
  • Stock Information
  • Founded
  • ASMB 2005
  • MGYR 1922
  • Country
  • ASMB United States
  • MGYR United States
  • Employees
  • ASMB N/A
  • MGYR N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • MGYR Savings Institutions
  • Sector
  • ASMB Health Care
  • MGYR Finance
  • Exchange
  • ASMB Nasdaq
  • MGYR Nasdaq
  • Market Cap
  • ASMB 84.5M
  • MGYR 94.1M
  • IPO Year
  • ASMB 2010
  • MGYR 2006
  • Fundamental
  • Price
  • ASMB $10.92
  • MGYR $14.12
  • Analyst Decision
  • ASMB Buy
  • MGYR
  • Analyst Count
  • ASMB 2
  • MGYR 0
  • Target Price
  • ASMB $35.00
  • MGYR N/A
  • AVG Volume (30 Days)
  • ASMB 29.4K
  • MGYR 2.0K
  • Earning Date
  • ASMB 03-27-2025
  • MGYR 04-22-2025
  • Dividend Yield
  • ASMB N/A
  • MGYR 1.77%
  • EPS Growth
  • ASMB N/A
  • MGYR 10.61
  • EPS
  • ASMB N/A
  • MGYR 1.30
  • Revenue
  • ASMB $28,326,000.00
  • MGYR $32,424,000.00
  • Revenue This Year
  • ASMB $282.16
  • MGYR N/A
  • Revenue Next Year
  • ASMB N/A
  • MGYR N/A
  • P/E Ratio
  • ASMB N/A
  • MGYR $10.82
  • Revenue Growth
  • ASMB N/A
  • MGYR 7.24
  • 52 Week Low
  • ASMB $10.56
  • MGYR $10.30
  • 52 Week High
  • ASMB $19.93
  • MGYR $14.90
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 33.39
  • MGYR 40.08
  • Support Level
  • ASMB $10.56
  • MGYR $14.11
  • Resistance Level
  • ASMB $13.07
  • MGYR $14.75
  • Average True Range (ATR)
  • ASMB 0.72
  • MGYR 0.21
  • MACD
  • ASMB -0.09
  • MGYR -0.07
  • Stochastic Oscillator
  • ASMB 15.44
  • MGYR 1.27

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.

Share on Social Networks: